Covishield, Covaxin cleared for regular market approval
India's two main vaccines -- Bharat Biotechs Covaxin and Serum Institute of India's Covishield -- on Wednesday got the nod for regular market authorisation.
Ensure only Covaxin is given to 15-18 group: Bharat Biotech
Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group.
Covaxin booster dose trial shows 'long-term safety': Bharat Biotech
Hyderabad-based vaccine manufacturer Bharat Biotech said on Saturday that its trials for Covaxin booster dose have shown 'long-term safety with no serious adverse events'.
Paracetamol not recommended after getting Covaxin jab: Bharat Biotech
Vaccine maker Bharat Biotech on Wednesday clarified that Paracetamol or pain killers are not recommended for teenagers after being vaccinated with Covaxin.
India supplies 5 lakh Covaxin doses to Afghanistan
India supplied humanitarian assistance consisting of 5,00,000 Covaxin doses to Afghanistan on Saturday, the Ministry of External Affairs said.
33.2 lakh students in TN to be given Covaxin from Jan 3
Tamil Nadu health department will be inoculating 33.2 lakh students with Covaxin from January 3 onwards.
Covaxin for children proven to be safe in paediatric subjects in study: Bharat Biotech
Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and imm
Only Covaxin to be administered to children aged 15-18 yrs
As the vaccination process for the teens aged 15 to 18 years will commence from January 3 across the nation, the government has said only Covaxin will be administered.